Monoclonal antibody therapies in the management of SARS-CoV-2 infection.

导出 OA

翻译打印收藏纠错

第一作者： Enrique,Miguez-Rey

第一单位： Enfermedades Infecciosas, Hospital Universitario de A Coruña, A Coruña, Spain.

作者： Enrique,Miguez-Rey ^[1] ; Dasom,Choi ^[2] ; Seungmin,Kim ^[2] ; Sangwook,Yoon ^[2] ; Oana,Săndulescu ^[3]

作者单位： Enfermedades Infecciosas, Hospital Universitario de A Coruña, A Coruña, Spain. ^[1] Celltrion Healthcare Co., Ltd., Incheon, Republic of Korea. ^[2] Department of Infectious Diseases, Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases 'Prof. Dr. Matei Balș', Bucharest, Romania. ^[3]

关键词 Bamlanivimab and etesevimab COVID-19 SARS-CoV-2 casirivimab and imdevimab neutralizing antibodies regdanvimab sotrovimab

主题词抗体, 单克隆(Antibodies, Monoclonal);抗体, 中和(Antibodies, Neutralizing);人类(Humans)

DOI 10.1080/13543784.2022.2030310

PMID 35164631

发布时间 2024-08-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交